# Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients

> **NCT05069662** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 120 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Directive Interview

## Key facts

- **NCT ID:** NCT05069662
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-05
- **Primary completion:** 2022-01-05
- **Final completion:** 2022-01-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069662, "Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05069662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*